Stockscreener 앱 받기
20.16
6.28%
-1.35
시간 외 거래:
19.57
-0.59
-2.93%
Bioage Labs Inc 주식(BIOA)의 최신 뉴스
BioAge Labs: Why Getting Into The Brain Might Be A Headache For Investors (NASDAQ:BIOA) - Seeking Alpha
The JPM Effect In Short Supply But BioAge And Bayer Gain - Citeline News & Insights
Bioage Labs Inc (BIOA) Stock Price Down 5.15% on Jan 16 - GuruFocus
Insider Selling: CEO Kristen Fortney Sells Shares of Bioage Labs Inc (BIOA) - GuruFocus
Insider Selling: BioAge Labs (NASDAQ:BIOA) CEO Sells 233,107 Shares of Stock - MarketBeat
Dov Md Goldstein Sells 27,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock - MarketBeat
Bioage Labs Insider Sold Shares Worth $4,223,036, According to a Recent SEC Filing - marketscreener.com
Bioage Labs Insider Sold Shares Worth $531,828, According to a Recent SEC Filing - marketscreener.com
BioAge Labs (NASDAQ:BIOA) Shares Up 7.1%Time to Buy? - MarketBeat
BioAge Labs extends rally after updating early-stage trial data for lead drug - Seeking Alpha
BioAge reports 86% reduction in inflammation markers with BGE-102 By Investing.com - Investing.com India
BioAge Labs (NASDAQ:BIOA) Reaches New 1-Year HighShould You Buy? - MarketBeat
BioAge stock soars 21% on positive data for inflammation drug By Investing.com - Investing.com South Africa
BioAge stock soars 21% on positive data for inflammation drug - Investing.com
BioAge Labs advances BGE-102 with strong Phase 1 data - TipRanks
BioAge Labs, Inc. Announces Positive Interim Phase 1 Data for BGE-102 - TradingView — Track All Markets
BioAge announces additional positive interim phase 1 data for BGE-102, a novel brain-penetrant NLRP3 inhibitor, demonstrating potential for best-in-class hsCRP reduction in participants with elevated cardiovascular risk - marketscreener.com
Experimental pill sharply cuts heart inflammation in 2 weeks - Stock Titan
Institutional investors are BioAge Labs, Inc.'s (NASDAQ:BIOA) biggest bettors and were rewarded after last week's US$51m market cap gain - simplywall.st
Weekly Earnings: Will The Chemours Company 2CU stock benefit from sector leadershipWeekly Trading Summary & Safe Capital Growth Plans - Bộ Nội Vụ
Is BioAge Labs Inc. stock dividend yield sustainableJuly 2025 Reactions & Fast Exit Strategy with Risk Control - Улправда
Can BioAge Labs Inc. stock deliver sustainable ROERelative Strength Index (RSI) & Individual Stock Tracking Service - bollywoodhelpline.com
Aug Ideas: Will BioAge Labs Inc. stock maintain growth storyRate Hike & Target Return Focused Stock Picks - Улправда
How analysts rate BioAge Labs Inc. stock todayJuly 2025 News Drivers & Reliable Momentum Entry Alerts - Улправда
Is BioAge Labs Inc. (Y7G) stock included in top ETFs2025 Pullback Review & Low Drawdown Momentum Trade Ideas - ulpravda.ru
What MACD trends signal for BioAge Labs Inc. (Y7G) stockQuarterly Risk Review & Verified Swing Trading Watchlist - Улправда
Why BioAge Labs Inc. stock could outperform in 20252025 Volume Leaders & Reliable Volume Spike Trade Alerts - Улправда
Aug Selloffs: Will BioAge Labs Inc. stock gain from lower inflationWeekly Profit Analysis & Scalable Portfolio Growth Methods - Улправда
BioAge Labs Hits New 52-Week High; Next Key Catalyst Due In 1H 2026 - RTTNews
BioAge Labs (NASDAQ:BIOA) Hits New 12-Month HighTime to Buy? - MarketBeat
BioAge Labs upgraded to equal weight from underweight at Morgan Stanley - MSN
BIOA INVESTORS: Kirby McInerney LLP Reminds BioAge Labs, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm - TMX Newsfile
BioAge Labs (NASDAQ:BIOA) Sets New 52-Week HighStill a Buy? - MarketBeat
Cash per share of BioAge Labs, Inc. – FWB:Y7G - TradingView — Track All Markets
BioAge Labs, Inc.(NasdaqGS: BIOA) added to NASDAQ Biotechnology Index - marketscreener.com
BioAge Labs announces positive phase 1 trial results - MSN
BioAge Labs (BIOA) Price Target Increased by 24.14% to 12.24 - Nasdaq
Can BioAge Labs Inc. stock continue upward trendMarket Activity Summary & Verified Momentum Stock Ideas - Улправда
Why BioAge Labs Inc. (Y7G) stock is listed among top recommendationsQuarterly Market Review & Risk Controlled Daily Trade Plans - DonanımHaber
What makes BioAge Labs Inc. stock attractive to growth fundsJuly 2025 Levels & Precise Swing Trade Alerts - DonanımHaber
Can BioAge Labs Inc. stock withstand economic slowdown2025 Technical Overview & Technical Confirmation Alerts - DonanımHaber
Bioage Labs Earnings Notes - Trefis
2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole - The Globe and Mail
2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole - The Motley Fool
1.30%
1.45%
자본화:
|
볼륨(24시간):